These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 8202329)
21. Evaluation of Cyfra 21-1 as a marker for lung cancer. Najemnik C; Mohn-Staudner A; Vetter H; Kokron O; Baumgartner G; Scheiner W; Zwick H; Koderhold G; Alth G; Dudczak R Wien Klin Wochenschr; 1996; 108(15):467-72. PubMed ID: 8806188 [TBL] [Abstract][Full Text] [Related]
22. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients. Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320 [TBL] [Abstract][Full Text] [Related]
23. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer. Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117 [TBL] [Abstract][Full Text] [Related]
24. [Tumor markers in lung cancer]. Niho S; Shinkai T Gan To Kagaku Ryoho; 2001 Dec; 28(13):2089-93. PubMed ID: 11791391 [TBL] [Abstract][Full Text] [Related]
25. Monitoring of therapy in inoperable lung cancer patients by measurement of CYFRA 21-1, TPA- TP CEA, and NSE. Ebert W; Hoppe M; Muley T; Drings P Anticancer Res; 1997; 17(4B):2875-8. PubMed ID: 9329552 [TBL] [Abstract][Full Text] [Related]
26. The prognostic value of both neuron-specific enolase (NSE) and Cyfra21-1 in small cell lung cancer. Ando S; Suzuki M; Yamamoto N; Iida T; Kimura H Anticancer Res; 2004; 24(3b):1941-6. PubMed ID: 15274381 [TBL] [Abstract][Full Text] [Related]
27. Biomarkers and IL-2R in lung cancer. Marino P; Preatoni A; Fonticoli L; Parodi M; Tarolo GL Recenti Prog Med; 1990 Nov; 81(11):702-4. PubMed ID: 1962891 [TBL] [Abstract][Full Text] [Related]
28. [Clinical value of combined detection of serum tumor markers in lung cancer diagnosis]. Chen F; Li WM; Wang DM; Gao SS; Bao Y; Chen WB; Liu D Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):832-5. PubMed ID: 19024326 [TBL] [Abstract][Full Text] [Related]
29. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma. Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038 [TBL] [Abstract][Full Text] [Related]
30. Usefulness of a multiple biomarker assay in bronchoalveolar lavage (BAL) and serum for the diagnosis of small cell lung cancer. Nikliński J; Chyczewska E; Furman M; Kowal E; Laudanski J; Chyczewski L Neoplasma; 1993; 40(5):305-8. PubMed ID: 8272160 [TBL] [Abstract][Full Text] [Related]
31. [Value of combined detection of tumor markers for the prediction of small cell and non-small cell lung cancer]. Wu Y; Wu Y; Wang L; Qu L Wei Sheng Yan Jiu; 2000 Jul; 29(4):213-5. PubMed ID: 12520921 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of the response to chemotherapy in patients affected with small cell lung cancer using discriminant analysis: a preliminary report. Paone G; De Angelis G; Pallotta G; Giannarelli D; Bisetti A; Pigorini F; Ameglio F Q J Nucl Med; 1995 Jun; 39(2):140-3. PubMed ID: 8574809 [TBL] [Abstract][Full Text] [Related]
33. [The value of serum tumor marker in the diagnosis of lung cancer]. Shi GL; Hu XL; Yue SD; Song CX Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):299-301. PubMed ID: 15996327 [TBL] [Abstract][Full Text] [Related]
34. Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer. Gaspar MJ; Diez M; Rodriguez A; Ratia T; Martin Duce A; Galvan M; Granell J; Coca C Anticancer Res; 2003; 23(4):3427-32. PubMed ID: 12926084 [TBL] [Abstract][Full Text] [Related]
35. ProGRP and NSE in therapy monitoring in patients with small cell lung cancer. Wójcik E; Kulpa JK; Sas-Korczyńska B; Korzeniowski S; Jakubowicz J Anticancer Res; 2008; 28(5B):3027-33. PubMed ID: 19031951 [TBL] [Abstract][Full Text] [Related]
36. Carcinoembryonic antigen, neuron-specific enolase and cytokeratin fragment 19 (CYFRA 21-1) levels in induced sputum of lung cancer patients. Hillas G; Moschos C; Dimakou K; Vlastos F; Avgeropoulou S; Christakopoulou I; Rasidakis A; Bakakos P Scand J Clin Lab Invest; 2008; 68(7):542-7. PubMed ID: 19378425 [TBL] [Abstract][Full Text] [Related]
37. [Tumor markers used in diagnosis and monitoring of primary bronchopulmonary carcinoma]. Mahler B Pneumologia; 2008; 57(3):175-7. PubMed ID: 18998332 [TBL] [Abstract][Full Text] [Related]
38. Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in monitoring first-line chemotherapy of small cell lung cancer. Holdenrieder S; von Pawel J; Dankelmann E; Duell T; Faderl B; Markus A; Siakavara M; Wagner H; Feldmann K; Hoffmann H; Raith H; Nagel D; Stieber P Clin Cancer Res; 2008 Dec; 14(23):7813-21. PubMed ID: 19047109 [TBL] [Abstract][Full Text] [Related]
39. Pre- and post-operative serum carcinoembryonic antigen in primary lung adenocarcinoma. Nonaka M; Kataoka D; Yamamoto S; Bito A; Matsuoka J; Kawada T; Takaba T Ann Thorac Cardiovasc Surg; 2004 Oct; 10(5):281-4. PubMed ID: 15563262 [TBL] [Abstract][Full Text] [Related]